Monte Rosa Therapeutics, Inc. Common Stock (NASDAQ: GLUE) last traded at $10.37, up 0.68% on the session. The quote above updates while this page is open; the figures below are drawn from Monte Rosa Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Monte Rosa Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker GLUE. Its market capitalisation is $884.70 million.
Valuation measures for Monte Rosa Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $884.70M |
|---|---|
| Enterprise value | $998.48M |
| Price / sales | 30.80 |
| Price / book | 1.82 |
| Beta | 1.05 |
Trailing-twelve-month figures tagged in Monte Rosa Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $28.73M |
|---|---|
| Net income (TTM) | -$161.09M |
| Operating margin | -633.04% |
| Return on equity | -33.06% |
| Cash | $90.10M |
Range and volume for GLUE over the past 52 weeks.
| 52-week high | $25.77 |
|---|---|
| 52-week low | $8.94 |
| Volume | 453.1K |
| Average volume | 1.30M |
| Previous close | $10.30 |
Invest a chosen dollar amount in Monte Rosa Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GLUE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.